• Skip to primary navigation
  • Skip to main content
  • Skip to footer
PanTher Therapeutics

PanTher Therapeutics

  • About Us
    • Mission
    • Team
  • Our Technology
    • Platform
    • Products
  • News
  • Careers
  • Contact

Therapeutics on target:

Attacking cancer at the source™

About Us

PanTher Therapeutics is a clinical-stage oncology company revolutionizing cancer care by harnessing sustained treatments engineered for localized applications. We are bringing the fight against cancer precisely to the target with our proprietary treatment platform, Sagittari™, designed to enhance therapeutic response with minimal side effects.

Learn more about us

Targeted Therapy Reimagined

At the core of PanTher’s approach is the ability to provide targeted, sustained, localized treatment, a property that enables more of the drug to reach and be retained at the tumor site.

Sagittari™ Platform

Our innovative Sagittari™ platform enables us to engineer optimized therapeutic solutions to address the specific challenges dictated by tumor type, location, and ideal therapeutic regimen.

Learn more about sagitarri

Pancreatic cancer and beyond

Our lead candidate, PTM-101, is a minimally invasive, implantable treatment for pancreatic cancer that provides direct, sustained release of the therapeutic agent at the tumor site. It is currently being evaluated in a Phase 1 clinical trial as first line therapy for localized non-metastatic pancreatic cancers.

Learn more about pancreatic cancer

For Partners

We are building a pipeline of Sagittari™ platform product candidates and actively evaluating co-development opportunities that leverage our targeted approach to address the highest unmet medical needs in oncology.

Learn more about our Sagittari™ platform and our growing pipeline

News

View All news posts

PanTher Presents Phase 1 Trial-In-Progress Poster for Pancreatic Cancer Study at American Society of Clinical Oncology Gastrointestinal Cancers Symposium

Jan 20, 2023 News

Read More about PanTher Presents Phase 1 Trial-In-Progress Poster for Pancreatic Cancer Study at American Society of Clinical Oncology Gastrointestinal Cancers Symposium

PanTher Therapeutics Billboard is Live in Times Square, New York, NY

Nov 7, 2022 News

Read More about PanTher Therapeutics Billboard is Live in Times Square, New York, NY

Footer

Twitter LinkedIn

PanTher Therapeutics, Inc

191 Dexter Ave
Watertown, MA, 02472

PanTher Therapeutics © 2022 All Rights Reserved

Terms of Use Privacy Policy Cookie Policy Accessibility Statement

logo
  • About Us
    • Mission
    • Team
  • Our Technology
    • Platform
    • Products
  • News
  • Careers
  • Contact